Final height in isolated GH deficiency type 1A: Effects of 5-year treatment with IGF-I

European Journal of Endocrinology

Volumn 144, Issue 4, 2001, Pages 379-383

  Messina, M F ^a   De Luca, F ^a   Wasniewska, M ^a   Valenzise, M ^a   Lombardo, F ^a   Ghizzoni, L ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; CLONIDINE; DNA; GROWTH HORMONE; GROWTH HORMONE ANTIBODY; GROWTH HORMONE RELEASING FACTOR; HUMAN GROWTH HORMONE; INSULIN; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; RESTRICTION ENDONUCLEASE; SOMATREM;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BODY HEIGHT; CASE REPORT; CHILD; DISEASE SEVERITY; FEMALE; GENE CLUSTER; GENE DELETION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; PARENT; PHENOTYPE; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; SIBLING;

EID: 0035041254     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1440379     Document Type: Article

References (31)

1. Molecular basis of human growth hormone gene deletions
2. Molecular basis for familial isolated growth hormone deficiency
3. Isolated growth hormone (GH) deficiency type IA associated with a double deletion in the human GH gene cluster
4. Phenotypic heterogeneity in familial isolated growth hormone deficiency type IA
5. Defects of growth hormone genes. Clinical syndromes
6. Growth hormone blocking antibodies in a patient with deletion of the GH-N gene
7. Growth hormone antibodies in patients treated with different preparations of human growth hormone (hGH)
8. Isolated growth hormone deficiency type 1 A associated with a 45-kilobase gene deletion within the human growth hormone gene cluster in an Italian family
9. Hereditary prenatal growth hormone deficiency with increased tendency to growth hormone antibody formation
10. Growth hormone gene deletion: Results of treatment with recombinant human insulin-like growth factor I
11. Insulin-like growth factor I improves height in growth hormone insensitivity: Two years' results
12. Insulin-like growth factor-I treatment in two children with growth hormone gene deletions
13. Treatment of isolated growth hormone deficiency type 1A due to GH-gene deletion with recombinant human insulin-like growth factor-I
14. Effects of insulin-like growth factor-I treatment on statural growth, body composition and phenotype of children with growth hormone insensitivity syndrome
15. A new type of familial growth hormone deficiency due to a 8.5 kb deletion within the growth hormone gene cluster
16. Isolated growth hormone deficiency due to the hGH-I gene deletion with (type IA) and without (the Israeli-type) hGH antibody formation during hGH therapy
17. Long term treatment of growth hormone insensitivity syndrome with IGF-I. Results of the European multicentre study - The working group on growth hormone insensitivity syndromes
18. Long-lasting catch-up growth under bio-methionyl growth hormone treatment in an infant with isolated growth hormone deficiency type 1A
19. Very late immune response to growth hormone (GH) therapy in an infant with GH-N gene deletion
20. Standards for children's height at age 2 to 9 years allowing for height of parents
21. Clinical longitudinal standards for height, weight, height velocity, weight velocity and the stages of puberty
22. Human growth hormone gene deletion without antibodies formation or growth arrest during treatment: A new disease entity?
23. Immunological aspects of human growth hormone
24. Congenital idiopathic growth hormone deficiency associated with prenatal and early post-natal growth failure
25. Somatotrophin in antenatal and perinatal growth and development
26. Auxological, clinical and neuroradiological findings in infants with early onset growth hormone deficiency
27. Current and potential uses of growth hormone and insulin-like growth factor-I
28. Growth response to rhIGF-I 80 mcg/kg twice daily in children with growth hormone insensitivity syndrome: Relationship to severity of clinical phenotype
29. Effects of insulin-like growth factor on linear growth, head circumference and body fat in patients with Laron-type dwarfism